Technology Crossover Management X’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.24M Hold
1,653,566
0.41% 6
2025
Q4
$4.48M Hold
1,653,566
0.45% 6
2025
Q3
$6.99M Hold
1,653,566
0.59% 7
2025
Q2
$8.23M Hold
1,653,566
0.92% 6
2025
Q1
$7.29M Hold
1,653,566
1.07% 6
2024
Q4
$7.69M Hold
1,653,566
1.1% 6
2024
Q3
$11.5M Hold
1,653,566
1.05% 6
2024
Q2
$12.9M Hold
1,653,566
1.27% 5
2024
Q1
$11.7M Hold
1,653,566
1.23% 5
2023
Q4
$11.1M Hold
1,653,566
1.31% 6
2023
Q3
$9.31M Hold
1,653,566
1.3% 6
2023
Q2
$9.13M Hold
1,653,566
0.9% 6
2023
Q1
$10.3M Hold
1,653,566
1.58% 6
2022
Q4
$7.71M Hold
1,653,566
1.38% 6
2022
Q3
$7.72M Hold
1,653,566
1.96% 6
2022
Q2
$9.79M Hold
1,653,566
2.73% 5
2022
Q1
$32M Hold
1,653,566
4.37% 4
2021
Q4
$54M Hold
1,653,566
5.83% 4
2021
Q3
$67.8M Buy
1,653,566
+317,981
+24% +$11.5M 20.38% 3
2021
Q2
$48.1M Buy
1,335,585
+391,000
+41% +$14.4M 13.15% 3
2021
Q1
$36.9M Buy
944,585
+444,585
+89% +$20M 8.52% 4
2020
Q4
$20.2M Buy
+500,000
New +$23M 4.67% 4

Other funds holding GDRX

Technology Crossover Management X's GDRX Position: Q1 2026 in Review

Technology Crossover Management X held its GoodRx Holdings (GDRX) position steady in Q1 2026 at 1,653,566 shares worth $3.24M. The position accounts for 0.41% of the portfolio, ranked #6.

Technology Crossover Management X first reported a position in GDRX in Q4 2020 and has held it in 22 quarters since. The position peaked at $67.8M in Q3 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Technology Crossover Management X held 1,653,566 shares of GoodRx Holdings worth $3.24M as of Q1 2026.
  • Technology Crossover Management X left its GoodRx Holdings share count unchanged in Q1 2026.
  • GoodRx Holdings made up 0.41% of Technology Crossover Management X's portfolio in Q1 2026, its #6 holding.
  • Technology Crossover Management X first reported a position in GoodRx Holdings in Q4 2020 and has held it in 22 quarters since.
  • Technology Crossover Management X's GoodRx Holdings position peaked at $67.8M in Q3 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Technology Crossover Management X's 13F filing for Q1 2026, filed 8 May 2026.